Saturday, October 3, 2026

USD/EUR Over 1% Down In The Last 21 Sessions

USD/EUR Over 1% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.94% for the last 21 sessions. At 14:11 EST on Sunday, 26 March, USD/EUR (USDEUR) is $0.93.

USD/EUR's yearly highs and lows, it's 3.892% up from its 52-week low and 11.372% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.60%, a negative 0.12%, and a positive 0.47%, respectively.

USD/EUR's highest amplitude of average volatility was 0.60% (last week), 0.56% (last month), and 0.47% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy price analysis: bounces off multi-week low, remains vulnerable below 61.8% fibo.. According to FXStreet on Friday, 24 March, "On the flip side, the daily swing low, around the 129.65 region, now seems to protect the immediate downside, below which the USD/JPY pair could fall to the 129.00 mark. ", "That said, a strong broad-based US Dollar (USD) rally lends some support to the USD/JPY pair and helps limit any further losses, at least for the time being."
  • Usd/jpy price analysis: bears poke 10-week-old support line near 130.50. According to FXStreet on Friday, 24 March, "Following that, the 130.00 round figure and multiple levels marked in February near 129.30, as well as near 128.00, could test the USD/JPY bears before directing them to the yearly low of 127.21.", "Alternatively, USD/JPY recovery can initially aim for the 50-DMA hurdle of 132.60. "
  • Usd/jpy remains heavily offered near 130.00 mark, its lowest level since February 10. According to FXStreet on Friday, 24 March, "This, in turn, is holding back bearish traders from placing fresh bets around the USD/JPY pair and helping limit the downside, at least for the time being. ", "This, along with the US bond yields, might influence the USD price dynamics and provide some impetus to the USD/JPY pair. "
  • Usd/jpy steadies near six-week low under 131.00 on mixed Japan inflation, US data eyed. According to FXStreet on Friday, 24 March, "Elsewhere, mixed US data and comments from US Treasury Secretary Janet Yellen also allow USD/JPY to lick its wounds.", "On the other hand, the US Treasury Secretary's testimony in front of the House Appropriations Financial Services Subcommittee probed the market's previous risk-on mood and allowed the USD/JPY to recover from multi-day low as she said, "China and Russia may want to develop an alternative to the US dollar," while also showing preparedness for additional deposit actions `if warranted'. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com